1. Home
  2. VIR vs PZZA Comparison

VIR vs PZZA Comparison

Compare VIR & PZZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • PZZA
  • Stock Information
  • Founded
  • VIR 2016
  • PZZA 1984
  • Country
  • VIR United States
  • PZZA United States
  • Employees
  • VIR N/A
  • PZZA N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • PZZA Restaurants
  • Sector
  • VIR Health Care
  • PZZA Consumer Discretionary
  • Exchange
  • VIR Nasdaq
  • PZZA Nasdaq
  • Market Cap
  • VIR 1.4B
  • PZZA 1.3B
  • IPO Year
  • VIR 2019
  • PZZA 1993
  • Fundamental
  • Price
  • VIR $9.70
  • PZZA $39.54
  • Analyst Decision
  • VIR Buy
  • PZZA Buy
  • Analyst Count
  • VIR 6
  • PZZA 13
  • Target Price
  • VIR $34.83
  • PZZA $56.36
  • AVG Volume (30 Days)
  • VIR 3.8M
  • PZZA 1.5M
  • Earning Date
  • VIR 02-20-2025
  • PZZA 02-27-2025
  • Dividend Yield
  • VIR N/A
  • PZZA 4.65%
  • EPS Growth
  • VIR N/A
  • PZZA 22.68
  • EPS
  • VIR N/A
  • PZZA 2.89
  • Revenue
  • VIR $78,618,000.00
  • PZZA $2,099,938,999.00
  • Revenue This Year
  • VIR N/A
  • PZZA N/A
  • Revenue Next Year
  • VIR N/A
  • PZZA $1.77
  • P/E Ratio
  • VIR N/A
  • PZZA $13.67
  • Revenue Growth
  • VIR N/A
  • PZZA 0.45
  • 52 Week Low
  • VIR $6.56
  • PZZA $35.28
  • 52 Week High
  • VIR $14.45
  • PZZA $76.91
  • Technical
  • Relative Strength Index (RSI)
  • VIR 52.17
  • PZZA 47.74
  • Support Level
  • VIR $10.09
  • PZZA $38.35
  • Resistance Level
  • VIR $11.39
  • PZZA $40.66
  • Average True Range (ATR)
  • VIR 0.71
  • PZZA 1.54
  • MACD
  • VIR -0.11
  • PZZA 0.50
  • Stochastic Oscillator
  • VIR 16.57
  • PZZA 79.18

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About PZZA Papa John's International Inc.

Papa John's is one of the largest players in the global QSR, or quick-service restaurant, pizza market, boasting more than 5,900 restaurants across nearly 50 countries at the end of 2023. The firm operates a predominantly franchised system, owning 11% of its restaurants and generating revenue from franchise royalties, sales of pizza and related products at its company-owned stores, and sales from its commissary supply chain. The firm is the fourth-largest limited-service pizza chain both in the US and globally, with a sizable presence in the UK, China, South Korea, and Chile.

Share on Social Networks: